Frennet 2011.

Methods	Multicentre phase II RCT
Participants	Frail elderly patients with newly diagnosed cancer Country: not reported Age: mean 79.3 years (SD 5.8) Sex: 57.7% women Inclusion criteria patients aged over 70 years newly diagnosed with cancer for which initiation of therapy was considered frail patients (VES‐13, score > 3/10) Exclusion criteria: VES‐13, score < 3/10 N randomised: (ongoing): IG: 53; CG: 58 N in analysis: not applicable (ongoing)
Interventions	Content of screen:Comprehensive geriatric assessment. Exact content of screen unclear Interventionist: not reported Intervention procedure: not reported Conditions for implementation: not reported Comparative condition: conventional oncological management Length of follow‐up: unclear, 6 months?
Outcomes	Primary outcomes: functional decline at 6 months (change in ADL score) Secondary outcomes: unclear Outcome time points: once at 6 months
Notes	Information from conference abstract available, no further information received from study authors